| |
|
|
Session 101
Poster Presentations Pathogenesis, Transmission, and Treatment of HHV-8/KSHV Disease Wednesday 1:30 - 3:30 pm Hall B |
| 807 | An Animal Model for Kaposi's Sarcoma C.H. Parsons*, D.H. Kedes Univ of Virginia, Charlottesville |
| 808 | Rhesus Macaque Rhadinovirus (RRV)-a Model to Decipher Kaposi's Sarcoma-associated Herpes Virus (KSHV) Capsid Structure and Protein Composition C. M. O'Connor*1, X. Yu2, B. Damania3, Z. H. Zhou2, D. H. Kedes1 1Univ of Virginia, Charlottesville; 2Univ of Texas-Houston Med Ctr; and 3Univ of North Carolina, Chapel Hill |
| 809 | Studies on the Transmission of HHV8 (KSHV) in Africa R. J. Biggar*1, S. Mbulaiteye1, M. Eltom1, A. Dada2, G. Brubaker3, D. Whitby4 1Natl Cancer Inst, Bethesda, MD; 2Hlth Promotion Consultancy, Lagos, Nigeria; 3Shirati Hosp, Tanzania; and 4Sci Applications Intl Corp, Frederick, MD |
| 810 | Genetic Evidence of Vertical Transmission of Kaposi’s Sarcoma-associated Herpesvirus (Human Herpesvirus 8) in Zambian Families O. Yegorov*1, T. M'soka1,2, J. Muyanga2, C. Kankasa2, G. Bhat2, T. Kapakala2, C. Chintu2, C. Mitchell3, J. T. West1, C. Wood1 1Univ of Nebraska, Lincoln; 2Univ Teaching Hosp, Lusaka, Zambia; and 3Univ of Miami, FL |
| 811 | Bloodborne Transmission of Kaposi's Sarcoma-associated Herpesvirus (Human Herpesvirus 8) in Children with Sickle Cell Disease S. Mbulaiteye*1, R. J. Biggar1, C. Ndugwa2, P. Bakaki2, R. Pfeiffer1, D. Whitby1, E. A. Engels1 1Natl Cancer Inst, Rockville, MD and 2Makerere Univ, Kampala, Uganda |
| 812 | Risk Factors for Kaposi's Sarcoma-associated Herpesvirus Infection among Homosexual Men at High Risk for HIV Infection in Brazil L. A. Lima*1,2, M. Schechter1, F. J. Jenkins3, P. S. Moore3,4, N. M. Renwick4, L. H. Harrison3 1Univ Federal do Rio de Janeiro, Brazil; 2Johns Hopkins Univ, Baltimore, MD; 3Univ of Pittsburgh, PA; and 4Columbia Univ, New York, NY |
| 813 | Genetic Polymorphisms of Endothelial Growth Factor Endothelin-1 May Modify Susceptibility to HIV-associated Kaposi's Sarcoma M. T. Dorak*, W. Shao, E. S. Lobashevsky, J. Tang, R. A. Kaslow Univ of Alabama at Birmingham |
| 814 | Immune Evasion by Kaposi's Sarcoma-associated Herpesvirus During Latency C. Tomescu*, W. K. Law, D. H. Kedes Univ of Virginia, Charlottesville |
| 815 | AIDS-related Kaposi's Sarcoma in 211 Patients: Assessment of the AIDS Clinical Trial Group Staging Classification Prognostic Value in the Era of HAART G. Nasti*1, R. Talamini1, A. Antinori2, F. Martellotta1, M. Fasan3, F. Chiodo4, G. Ballardini5, L. Stoppini6, G. Di Perri7, M. Mena8, M. Tavio1, E. Vaccher1, A. D'Arminio Monforte3, U. Tirelli1 1Ctr di Riferimento Oncologico, Aviano, Italy; 2Inst di Ricovero e Cura a Carattere Sci (IRCCS) Spallanzani, Roma, Italy; 3Hosp Sacco, Milano, Italy; 4Policlinico S Orsola, Bologna, Italy; 5Hosp St Croce, Ravenna, Italy; 6Hosp Civile, Pesaro, Italy; 7Hosp Amedeo di Savoia, Torino, Italy; and 8Hosp di Cuggiono, Italy |
| 816 | Preliminary Results of Combination Liposomal Doxorubicin and Interleukin-12 Followed by Chronic IL-12 Maintenance Therapy in Advanced AIDS-related Kaposi’s Sarcoma R. F. Little*, K. Aleman, Merced, K. Wyvill, A. Catanzaro, F. Maldarelli, S. M. Steinberg, R. Yarchoan Natl Cancer Inst, Bethesda, MD |
| 816a | Multiple human herpesvirus 8 infection C G Teo*1, M Al-Bayari2, R D Cook2, T A Hodgson2, S R Porter2, E Borgstein3, E M Molyneux3 1Virus Reference Division, PHLS Central Public Helath Laboratory, London, UK; 2Eastman Institute for Oral Hlth Care Scis, University College London, UK; and 3College of Medicine, University of Malawi, Blantyre, Malawi |